ReviewApplied microbiology and biotechnology2025
Micro-aeration for improving anaerobic treatment and biogas production from organic pollutants.
Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Coupled enhancement of sulfate-assisted anaerobic digestion for livestock wastewater treatment under antibiotic stress using sludge-derived biochar and zero-valent iron.Bioprocess and biosystems engineering · 2026Article
- Anaerobic microbial degradation of persistent organic pollutants in aquatic sediments: implications of climate change.Archives of microbiology · 2025Review
- Enhancing Anaerobic Digestion of Agricultural By-Products: Insights and Future Directions in Microaeration.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Anaerobic digestion (AD) is a well-established method for waste/wastewater treatment and biogas production, but challenges remain in improving its performance, particularly for toxic/inhibitory organic compounds such as lipids, hydrocarbons, polyphenols, pharmaceuticals, and other pollutants. Micro-aeration, which involves the controlled introduction of small amounts of oxygen, has emerged as a promising strategy to enhance microbial activity, stimulate the degradation of challenging compounds, and improve methane yields. This review addresses the different strategies used for effective oxygen dosing, measurement, and control, while also delving into the bioenergetics of the coexisting anaerobic and micro-aerobic pathways. Studies demonstrating the potential of micro-aeration to enhance the anaerobic treatment of recalcitrant organic pollutants, such as BTEX (benzene, toluene, ethylbenzene, and xylene) and pharmaceutical compounds, are reviewed. Several works use micro-aeration as a pretreatment, while those implementing it directly within bioreactors typically apply it intermittently. Nevertheless, in most cases, the application of micro-aeration is guided by a "trial-and-error" approach, and a systematic understanding of optimal strategies and dosing for different classes of pollutants remains lacking. The review also explores the diverse roles of micro-aeration in the AD of lipids, highlighting key microorganisms and underlying mechanisms that drive these processes, for instance, the role of facultative anaerobes in converting oleate into palmitate and protecting methanogenic communities. Finally, this work highlights future directions and remaining challenges in applying micro-aeration for the anaerobic treatment of organic pollutants. KEY POINTS: AD of lipids, hydrocarbons, dyes, pharmaceuticals, and other pollutants is challenging. Micro-aeration reshapes microbial communities and enhances pollutant degradation. Effective micro-aeration depends on several factors and is not fully mastered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.